Southam L, Zeggini E. Twenty years of genome-wide association studies. Nature. 2025;641:47–9.
Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–9.
Loos RJF. 15 years of genome-wide association studies and no signs of slowing down. Nat Commun. 2020;11:5900.
Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447:661–78.
Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012;90:7–24.
Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet. 2017;101:5–22.
Abdellaoui A, Yengo L, Verweij KJH, Visscher PM. 15 years of GWAS discovery: Realizing the promise. Am J Hum Genet. 2023;110:179–94.
Consortium I-RMRA. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214–24.
Scott S, Sangkuhl K, Stein C, Hulot JS, Mega J, Roden D, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharm Ther. 2013;94:317–23.
Gaudet D, Alexander VJ, Baker BF, Brisson D, Tremblay K, Singleton W, et al. Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia. N Engl J Med. 2015;373:438–47.
Mullard A. How GLP-1 went from being a hard-to-handle hormone to a blockbuster success. Nat Rev Drug Discov. 2024;23:889–90.
Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34:154–6.
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–22.
Trajanoska K, Bherer C, Taliun D, Zhou S, Richards JB, Mooser V. From target discovery to clinical drug development with human genetics. Nature. 2023;620:737–45.
Yengo L, Vedantam S, Marouli E, Sidorenko J, Bartell E, Sakaue S, et al. A saturated map of common genetic variants associated with human height. Nature. 2022;610:704–12.
Visscher PM, Goddard ME. From R.A. Fisher’s 1918 Paper to GWAS a Century Later. Genetics. 2019;211:1125–30.
Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23:120–33.
Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024;332:571–84.
Wand H, Lambert SA, Tamburro C, Iacocca MA, O’Sullivan JW, Sillari C, et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature. 2021;591:211–9.
Inouye M, Abraham G, Nelson CP, Wood AM, Sweeting MJ, Dudbridge F, et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. J Am Coll Cardiol. 2018;72:1883–93.
Kumar A, Im K, Banjevic M, Ng PC, Tunstall T, Garcia G, et al. Whole-genome risk prediction of common diseases in human preimplantation embryos. Nat Med. 2022;28:513–6.
Check Hayden E. The rise and fall and rise again of 23andMe. Nature. 2017;550:174–7.
Eisenstein M. Every base everywhere all at once: pangenomics comes of age. Nature. 2023;616:618–20.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
Gagliano Taliun SA, VandeHaar P, Boughton AP, Welch RP, Taliun D, Schmidt EM, et al. Exploring and visualizing large-scale genetic associations by using PheWeb. Nat Genet. 2020;52:550–2.
Uffelmann E, Huang QQ, Munung NS, De Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. Nat Rev Methods Prim. 2021;1:59.
Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics C, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291–5.
Prive F, Arbel J, Vilhjalmsson BJ. LDpred2: better, faster, stronger. Bioinformatics. 2021;36:5424–31.
Salehi Nowbandegani P, Wohns AW, Ballard JL, Lander ES, Bloemendal A, Neale BM, et al. Extremely sparse models of linkage disequilibrium in ancestrally diverse association studies. Nat Genet. 2023;55:1494–502.
Huang J, Howie B, McCarthy S, Memari Y, Walter K, Min JL, et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat Commun. 2015;6:8111.
Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, et al. Genetic Misdiagnoses and the Potential for Health Disparities. N Engl J Med. 2016;375:655–65.
Ganna A, Verweij KJH, Nivard MG, Maier R, Wedow R, Busch AS, et al. Large-scale GWAS reveals insights into the genetic architecture of same-sex sexual behavior. Science. 2019;365:eaat7693.
Hill WD, Davies NM, Ritchie SJ, Skene NG, Bryois J, Bell S, et al. Genome-wide analysis identifies molecular systems and 149 genetic loci associated with income. Nat Commun. 2019;10:5741.
Guo J, Yang J, Visscher PM. Leveraging GWAS for complex traits to detect signatures of natural selection in humans. Curr Opin Genet Dev. 2018;53:9–14.
Howe LJ, Nivard MG, Morris TT, Hansen AF, Rasheed H, Cho Y, et al. Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects. Nat Genet. 2022;54:581–92.
Kim B, Kim DS, Shin JG, Leem S, Cho M, Kim H, et al. Mapping and annotating genomic loci to prioritize genes and implicate distinct polygenic adaptations for skin color. Nat Commun. 2024;15:4874.
Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafo MR, et al. Mendelian randomization. Nat Rev Methods Primers. 2022;2:6.
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40:1652–66.
Rambaut A, Holmes EC, O’Toole A, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5:1403–7.
Shu Y, McCauley J GISAID: Global initiative on sharing all influenza data – from vision to reality. Euro Surveill. 2017;22:30494.
Wierbowski SD, Liang S, Liu Y, Chen Y, Gupta S, Andre NM, et al. A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations. Nat Methods. 2021;18:1477–88.
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–9.
Szell M, Ma Y, Sinatra R. Was the Nobel prize for physics? Yes – not that it matters. Nature. 2024;634:782.
Cheng J, Novati G, Pan J, Bycroft C, Zemgulyte A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492.
Poplin R, Chang PC, Alexander D, Schwartz S, Colthurst T, Ku A, et al. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol. 2018;36:983–7.
Deelder W, Benavente ED, Phelan J, Manko E, Campino S, Palla L, et al. Using deep learning to identify recent positive selection in malaria parasite sequence data. Malar J. 2021;20:270.
Malina S, Cizin D, Knowles DA. Deep mendelian randomization: Investigating the causal knowledge of genomic deep learning models. PLoS Comput Biol. 2022;18:e1009880.
BAKER D Government Efficiency and DOGE Government Efficiency. CounterPunch. 2025.
Aguet F, Alasoo K, Li YI, Battle A, Im HK, Montgomery SB, et al. Molecular quantitative trait loci. Nat Rev Methods Prim. 2023;3:4.
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–43.
Ridker PM, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med. 2024;391:2087–97.
Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359:1897–908.
Huang J, Mi Y, Li J, McLean GR. SARS-Cov-2 variants: biological and mathematical considerations for nomenclature. Med Res Arch. 2022;6:1–8.